PK68 是一种高效、特异性、具有口服活性的受体相互作用激酶 1 (RIPK1) II 型抑制剂,IC50 值约 90 nM,可抑制 RIPK1 依赖性坏死,对 TNF 诱导的全身炎症反应综合征有较强的改善作用,可用于炎症紊乱和肿瘤转移的研究。
产品编号: MS-C38546 纯度: 99.92% CAS No.: 2173556-69-7 分子式: C22H24N4O3S 分子量: 424.52
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
10mM * 1mL in DMSO
询价
3-5 天
1mg
询价
3-5 天
5mg
询价
3-5 天
10mg
询价
3-5 天
25mg
询价
3-5 天
50mg
询价
询价
100mg
询价
询价
500mg
询价
询价
1g
询价
询价
5g
询价
询价

产品描述

PK68 是一种高效、特异性、具有口服活性的受体相互作用激酶 1 (RIPK1) II 型抑制剂,IC50 值约 90 nM,可抑制 RIPK1 依赖性坏死,对 TNF 诱导的全身炎症反应综合征有较强的改善作用,可用于炎症紊乱和肿瘤转移的研究。

生物实验数据

生物活性 PK68 is a potent, specific, and orally active type II inhibitor of receptor-interacting protein kinase 1 (RIPK1) with an IC50 of approximately 90 nM that inhibits RIPK1-dependent necrosis, exerts a strong ameliorative effect on TNF-induced systemic inflammatory response syndrome, and can be used for research on inflammatory disorders and tumor metastasis.
IC50 & Target RIPK1:90 nM
体外研究
(In Vitro)

PK68 has highly potent inhibition of TNF-induced necroptosis with EC50 values of 23 nM and 13 nM in human and mouse cells, respectively.
PK68 is a highly selective inhibitor of RIPK1 kinase activity with IC50 value of 90 nM.
PK68 (100 nM, 1 h) blocks necroptosis through the suppression of RIPK3 function or signaling upstream of RIPK3 activation.

Cell Viability Assay

Cell Line: Bone marrow-derived macrophages, NIH3T3-RIPK3 cells
Concentration: 100 nM
Incubation Time: 1 h
Result: PK68 block cellular activation of RIPK1, RIPK3, and MLKL upon necroptotic stimuli.
PK68 inhibit TNF-induced necroptosis but not RIPK3 dimerization-induced cell death in NIH3T3-RIPK3 cells.

Western Blot Analysis

Cell Line: HT-29 cells
Concentration: 100 nM
Incubation Time: 1 h
Result: Completely abolished phosphorylation of RIPK1, RIPK3, and MLKL.

Immunofluorescence

Cell Line: HT-29 cells
Concentration: 100 nM
Incubation Time: 1 h
Result: Prevented generation of RIPK3 puncta.
体内研究
(In Vivo)

PK68 (5 mg/kg, 25 mg/kg; oral gavage; daily; for 7 days) or (2 mg/kg, i.v.; 10 mg/kg, p.o.; for 14 days) exhibits a favorable pharmacokinetic profile and no obvious toxicity in mice.
PK68 (1 mg/kg, i.p.) ameliorates TNF-induced systemic inflammatory response syndrome.
PK68 (5 mg/kg, i.v.) inhibits RIPK1 that results in attenuated tumor cell transmigration across the endothelial barrier and preventive suppression of tumor metastasis.

Animal Model: C57BL/6 mice
Dosage: 5 mg/kg, 25 mg/kg
Administration: 5 mg/kg, 25 mg/kg; oral gavage; daily; for 7 days
Result: Exhibited favorable pharmacokinetic profiles and no obvious toxicity in mice treated with a 14-day course at a dose of 25 mg/kg.
Animal Model: C57BL/6 mice
Dosage: 2 mg/kg, 10 mg/kg
Administration: 2 mg/kg, i.v.; 10 mg/kg, p.o; for 14 days
Result:
PO (Gavage) IV (Bolus)
Tmax (hr) 0.5
Cmax (ng/mL) 2423
AUC0-24 (ng/mL•hr) 4821 1588
AUCINF (ng/mL•hr) 4897 1590
t1/2 (hr) 1.3 1.0
MRT (hr) 1.8 0.8
CL (mL/hr/kg) 1258
CL (mL/min/kg) 21
Vss (mL/kg) 1009
Vss (L/kg) 1.0
F(%) 61
Animal Model: C57BL/6 mice
Dosage: 1 mg/kg
Administration: 1 mg/kg, i.p.
Result: Provided effective protection against TNFα-induced lethal shock.
Animal Model: C57BL/6 mice
Dosage: 5 mg/kg
Administration: 5 mg/kg, i.v.
Result: Significantly reduced the number of pulmonary metastasis nodules, decreased lung metastasis, decreased number of RFP-LL/2 cells, attenuated transmigration of RFP-LL/2 cells through the endothelial cell monolayer and had no obvious influence on the proliferation rate and invasion ability of B16-F10 or RFP-LL/2 cells without the endothelial cell monolayer in vitro.
性状 固体
颜色 Off-white to light yellow

化学信息

分子量 424.52
分子式 C22H24N4O3S
CAS No. 2173556-69-7

储存&溶解度

体内实验配方
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (2.36 mM), Sonication is recommended.
请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。
储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMSO 中的溶解度 : 30 mg/mL (70.67 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

可选溶剂浓度1 mg5 mg10 mg25 mg
DMSO1 mM2.3556 mL11.7780 mL23.5560 mL58.8900 mL
5 mM0.4711 mL2.3556 mL4.7112 mL11.7780 mL
10 mM0.2356 mL1.1778 mL2.3556 mL5.8890 mL
15 mM0.1570 mL0.7852 mL1.5704 mL3.9260 mL
20 mM0.1178 mL0.5889 mL1.1778 mL2.9445 mL
25 mM0.0942 mL0.4711 mL0.9422 mL2.3556 mL
30 mM0.0785 mL0.3926 mL0.7852 mL1.9630 mL
40 mM0.0589 mL0.2945 mL0.5889 mL1.4723 mL
50 mM0.0471 mL0.2356 mL0.4711 mL1.1778 mL
60 mM0.0393 mL0.1963 mL0.3926 mL0.9815 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础